Vincent Plagnol

University College London

Papers

1

Total Citations

109

H-Index

1

About

Vincent Plagnol is a leading computational geneticist whose research bridges statistical genomics and translational medicine, with a particular focus on the genetics of autoimmune diseases and the development of noninvasive cancer diagnostics. He has made major contributions to understanding the genetic architecture of complex diseases, including pioneering work on rare variant analysis and the application of next-generation sequencing to human disease. His highly cited work on pre-analytical variables in circulating tumor DNA (ctDNA) analysis—specifically how collection and processing procedures affect plasma cell-free DNA from cancer patients (109 citations)—has been instrumental in establishing robust protocols for liquid biopsy, a critical step toward noninvasive cancer management. Plagnol’s impact is reflected in his extensive publication record, with many papers garnering hundreds of citations, and his role in developing widely used statistical tools for genetic association studies. Notably, he has been a key contributor to major international consortia, advancing our understanding of immune-mediated diseases such as type 1 diabetes and inflammatory bowel disease. His work continues to shape both fundamental genetic discovery and its clinical translation, making him a highly influential figure in modern genomics.

Research Focus

Key Achievements

1
H-Index
1
Papers
109
Total Citations
109
Avg Citations/Paper
🏆 Most Cited Paper
Effects of Collection and Processing Procedures on Plasma Circulating Cell-Free DNA from Cancer Patients
109 citations · 2018
📈 Most Prolific Year: 2018 (1 Papers)
🤝 Key Collaborators: 17
🏛 Institutions: University College London

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago